サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1494311

欧州のdPCRとqPCR：2030年市場予測- 地域別分析- 治療、製品、用途、エンドユーザー別

Europe dPCR and qPCR Market Forecast to 2030 - Regional Analysis - By Treatment, Product, Application, and End User

出版日
ページ情報
英文 107 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
欧州のdPCRとqPCR：2030年市場予測- 地域別分析- 治療、製品、用途、エンドユーザー別
出版日: 2024年03月14日
発行: The Insight Partners
ページ情報: 英文 107 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州のdPCRとqPCR市場は、2022年に25億7,383万米ドルと評価され、2030年には51億8,296万米ドルに達すると予測され、2022年から2030年までのCAGRは9.1%で成長すると予測されています。

遺伝性疾患と感染症の増加が欧州のdPCRとqPCR市場を牽引

国家機関の遺伝性疾患または先天性障害に関する情報によると、個々の遺伝性疾患はまれであるが、全体として遺伝性疾患と診断される人は15,500人を超えます。Novartis AG（スイス）の報告によると、2020年6月には、15,000人が鎌状赤血球症を患っており、毎年270人の新生児が鎌状赤血球症と診断されています。COVID-19の発生はポリメラーゼ連鎖反応市場の成長に大きな影響を与えました。臨床診断市場における需要の増大はPCR産業に好影響を及ぼしています。ほぼすべての診断検査は、COVID-19の症状がありヘルスケア専門家から診断検査を受けるよう促された人々を検査するためにRT-PCRを使用しているが、当局はウイルス培養検査を支持していないです。バイオテクノロジーや製薬企業の大半は、COVID-19に対する新規化合物や治療法の発見に向け、研究開発部門に力を注いでいた。2022年2月、ロシュはCE認証を受け入れる国で使用するCOVID-19 PCRのポートフォリオに、新たにリリースされた分子検査機器であるコバス5800システムを追加しました。これらの製品には、コバスSARS-CoV-2およびインフルエンザA/B検査、コバスSARS-CoV-2定性検査が含まれます。ロシュ・ダイアグノスティックスは、これらの製品により、少量、中量、多量の分子検査ニーズに均一な性能と効率性を提供することで、分子検査製品ラインアップの幅を広げています。さらに、スペースやリソースが限られているヘルスケア機関でも、コンパクトな新型コバス5800システムにより、包括的なアクセスが可能になります。リソースやスペースの不足のために大型の装置を設置できない国や環境では、検査へのアクセス性が向上します。このように、dPCRとqPCR技術が診断や治療に使用できる遺伝性疾患や感染性疾患の発生率の増加が、欧州のdPCRとqPCR市場の成長を支えています。

欧州のdPCRとqPCR市場概要

欧州のdPCRとqPCR市場は、ドイツ、英国、フランス、イタリア、スペイン、その他欧州に区分されます。先端研究のための政府や民間からの資金援助、人工DNA合成のための革新的技術の発表、新規技術に基づく用途のための様々な研究の増加が、欧州におけるこの市場の成長を促進する主な要因であると考えられます。加えて、研究開発や新規バイオベンチャー企業に対する優遇措置や免税措置を通じてイノベーションを奨励する各国政府の取り組みも、予測期間を通じて欧州のdPCRとqPCR市場の成長に有利に働くと予想されます。しかし、欧州連合（EU）に対するブレグジットの影響により、さまざまな提携、パートナーシップ、ベンチャー、共同事業が失われ、欧州のdPCRとqPCR市場にマイナスの影響を与える可能性があります。

欧州のdPCRとqPCR市場の収益と2030年までの予測（金額）

欧州のdPCRとqPCR市場のセグメンテーション

欧州のdPCRとqPCR市場は、治療、製品、用途、エンドユーザー、国に基づいてセグメント化されます。

治療に基づき、欧州のdPCRとqPCR市場は定量PCR（qPCR）とデジタルPCR（dPCR）に二分されます。デジタルPCR（dPCR）セグメントは2022年に大きなシェアを占めました。

製品別では、欧州のdPCRとqPCR市場は試薬&消耗品、機器、ソフトウェア&サービスに区分されます。2022年には試薬＆消耗品セグメントが最大のシェアを占めました。

用途別では、欧州のdPCRとqPCR市場は研究用途、臨床用途、法医学用途に区分されます。2022年には臨床応用分野が最大のシェアを占めました。臨床用途セグメントはさらに、腫瘍学検査、血液スクリーニング、感染症検査、その他の用途に細分化されます。

エンドユーザー別では、欧州のdPCRとqPCR市場は、病院・診断センター、製薬・バイオテクノロジー企業、研究所・学術機関、法医学研究所、臨床研究機関に区分されます。病院と診断センターセグメントが2022年に最大のシェアを占めました。

国別では、欧州のdPCRとqPCR市場は、英国、ドイツ、フランス、スペイン、イタリア、その他欧州に区分されます。ドイツが2022年の欧州のdPCRとqPCR市場を独占しました。

Abbott Laboratories、Thermo Fisher Scientific Inc、Takara Bio Inc、Qiagen NV、Standard BioTools Inc、Lepu Medical Technology Beijing Co Ltd、F. Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc、Agilent Technologies Incは、欧州のdPCRとqPCR市場で事業を展開している大手企業の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州のdPCRとqPCR市場情勢

  • 欧州PEST分析

第5章 欧州のdPCRとqPCR市場：主要産業力学

  • 市場促進要因
    • 遺伝病および感染症の発生率の増加
    • 遺伝子合成への投資と資金の増加
    • PCR技術の技術的進歩
  • 市場抑制要因
    • PCRシステムの高コスト
    • qPCRに伴う技術的限界
  • 市場機会
    • 新興国におけるPCR法の採用拡大
  • 今後の動向
    • 液滴デジタルPCRの発展
  • 影響分析

第6章 dPCRとqPCR市場：欧州市場分析

  • 欧州のdPCRとqPCR市場収益、2022年～2030年

第7章 欧州のdPCRとqPCR市場-2030年までの収益と予測：治療別

  • 欧州のdPCRとqPCR市場収益シェア、治療別、2022年および2030年（%）
  • 定量的PCR
  • デジタルPCR

第8章 欧州のdPCRとqPCR市場：2030年までの収益と予測：製品別

  • 欧州のdPCRとqPCR市場：2022年および2030年の製品別売上高シェア（%）
  • 試薬・消耗品
  • 装置
  • ソフトウェア＆サービス

第9章 欧州のdPCRとqPCR市場：2030年までの収益と予測：用途別

  • 欧州のdPCRとqPCR市場の2022年および2030年の用途別収益シェア（%）
  • 調査用途
  • 臨床用途
  • 法医学用途

第10章 欧州のdPCRとqPCR市場：エンドユーザー別収益と2030年までの予測

  • 欧州のdPCRとqPCR市場エンドユーザー別収益シェア（2022年および2030年）
  • 病院および診断センター
  • 製薬会社およびバイオテクノロジー企業
  • 研究機関および学術機関
  • 法医学研究所
  • 臨床研究機関

第11章 欧州のdPCRとqPCR市場：国別分析

    • 欧州のdPCRとqPCR市場：国別
      • 英国
      • ドイツ
      • フランス
      • イタリア
      • スペイン
      • その他欧州

第12章 dPCRとqPCR市場-業界情勢

  • 欧州のdPCRとqPCR市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第13章 企業プロファイル

  • Abbott Laboratories
  • Thermo Fisher Scientific Inc
  • Takara Bio Inc
  • Qiagen NV
  • Standard BioTools Inc
  • Lepu Medical Technology Beijing Co Ltd
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Agilent Technologies Inc

第14章 付録

図表

List Of Tables

  • Table 1. Europe dPCR and qPCR Market Segmentation
  • Table 2. Europe dPCR and qPCR Market, by Clinical Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. UK: Europe dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. UK: Europe dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. UK: Europe dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. UK: Europe dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. UK: Europe dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Germany: Europe dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Germany: Europe dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Germany: Europe dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Germany: Europe dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Germany: Europe dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. France: Europe dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. France: Europe dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. France: Europe dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. France: Europe dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. France: Europe dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Italy: Europe dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Italy: Europe dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Italy: Europe dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Italy: Europe dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Italy: Europe dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Spain: Europe dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Spain: Europe dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Spain: Europe dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Spain: Europe dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Spain: Europe dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. Rest of Europe: Europe dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. Rest of Europe: Europe dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. Rest of Europe: Europe dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. Rest of Europe: Europe dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Rest of Europe: Europe dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Recent Organic Growth Strategies in Europe dPCR and qPCR Market
  • Table 34. Recent Inorganic Growth Strategies in the Europe dPCR and qPCR Market
  • Table 35. Glossary of Terms, Europe dPCR and qPCR Market

List Of Figures

  • Figure 1. Europe dPCR and qPCR Market Segmentation, By Country
  • Figure 2. Europe - PEST Analysis
  • Figure 3. Europe dPCR and qPCR Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Europe dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Europe dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • Figure 7. Quantitative PCR: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Digital PCR: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Europe dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
  • Figure 10. Reagents & Consumables: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Instruments: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Software & Services: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Europe dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
  • Figure 14. Research Application: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Clinical Application: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Forensic Application: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Europe dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
  • Figure 18. Hospitals and Diagnostic Centers: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Pharmaceutical and Biotechnology Companies: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Research Laboratories and Academic Institutes: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Forensic Laboratories: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Clinical Research Organizations: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Europe dPCR and qPCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 24. Europe dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
  • Figure 25. UK: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Germany: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. France: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Italy: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Spain: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Rest of Europe: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 31. Growth Strategies in Europe dPCR and qPCR Market
目次
Product Code: BMIRE00029879

The Europe dPCR and qPCR market was valued at US$ 2,573.83 million in 2022 and is expected to reach US$ 5,182.96 million by 2030; it is estimated to grow at a CAGR of 9.1% from 2022 to 2030.

Increasing Incidence of Genetic and Infectious Diseases Drive Europe dPCR and qPCR Market

According to the National Organization's information on genetic conditions or congenital disabilities, though individual genetic disorders are rare, collectively, they comprise over 15,500 people diagnosed with genetic disorders. In June 2020, as per Novartis AG (Switzerland) report, ~15,000 individuals have sickle cell disease, and 270 newborns are diagnosed with the condition every year. The COVID-19 outbreak had a significant effect on the polymerase chain reaction market growth. The growing demand in the clinical diagnostic market has a favorable effect on the PCR industry. Nearly all diagnostic tests use RT-PCR to test the people having symptoms of COVID-19 and were urged by healthcare experts to undergo a diagnostic test, while the authorities have not endorsed viral culture tests. The majority of biotech and pharmaceutical businesses were concentrating their efforts on research and development divisions to find novel compounds or therapy approaches for COVID-19. In February 2022, Roche added the Cobas 5800 System, a newly released molecular laboratory instrument, to its COVID-19 PCR portfolio for use in nations that accept the CE certification. These product include the cobas SARS-CoV-2 and influenza A/B tests, as well as the cobas SARS-CoV-2 qualitative test. By offering uniform performance and efficiency across low-, medium--, and high-volume molecular laboratory testing needs, these products broaden the Roche Diagnostics molecular portfolio offering. Additionally, healthcare organizations with limited space or resources can have comprehensive access owing to the new, compact Cobas 5800 System. Better testing accessibility will result from this in nations or settings where larger equipment cannot be accommodated due to a lack of resources or space. Thus, increasing incidence of genetic and infectious diseases in which dPCR and qPCR techniques can be used for diagnosis and treatments support the growth of the Europe dPCR and qPCR market.

Europe dPCR and qPCR Market Overview

The European dPCR and qPCR market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Government and private funding for advanced research, the launch of innovative technologies for artificial DNA synthesis, and an increase in various research for novel technology-based applications are likely to be the major factors driving the growth of this market in Europe. In addition, efforts taken by the national governments to encourage innovation through incentive provisions and tax exemption for R&D and new biotech startups are expected to favor the European dPCR and qPCR market growth over the forecast years. However, the effect of Brexit on the European Union may lead to the loss of various alliances, partnerships, ventures, and collaborations, negatively impacting the European dPCR and qPCR market.

Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Million)

Europe dPCR and qPCR Market Segmentation

The Europe dPCR and qPCR market is segmented based on treatment, product, application, end user, and country.

Based on treatment, the Europe dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held a larger share in 2022.

By product, the Europe dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share in 2022.

By application, the Europe dPCR and qPCR market is segmented into research application, clinical application, and forensic application. The clinical application segment held the largest share in 2022. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.

By end user, the Europe dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held the largest share in 2022.

Based on country, the Europe dPCR and qPCR market is segmented into the UK, Germany, France, Spain, Italy, and the Rest of Europe. Germany dominated the Europe dPCR and qPCR market in 2022.

Abbott Laboratories, Thermo Fisher Scientific Inc, Takara Bio Inc, Qiagen NV, Standard BioTools Inc, Lepu Medical Technology Beijing Co Ltd, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, and Agilent Technologies Inc are some of the leading companies operating in the Europe dPCR and qPCR market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe dPCR and qPCR Market Landscape

  • 4.1 Overview
  • 4.2 Europe PEST Analysis

5. Europe dPCR and qPCR Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Incidence of Genetic and Infectious Diseases
    • 5.1.2 Rising Investments and Funds for Gene Synthesis
    • 5.1.3 Technological Advancements in PCR Technologies
  • 5.2 Market Restraints
    • 5.2.1 High Costs of PCR Systems
    • 5.2.2 Technical Limitations Associated with qPCR
  • 5.3 Market Opportunities
    • 5.3.1 Growing Adoption of PCR Methods in Emerging Countries
  • 5.4 Future Trends
    • 5.4.1 Development of Droplet Digital PCR
  • 5.5 Impact Analysis:

6. dPCR and qPCR Market - Europe Market Analysis

  • 6.1 Europe dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030

7. Europe dPCR and qPCR Market - Revenue and Forecast to 2030 - by Treatment

  • 7.1 Overview
  • 7.2 Europe dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • 7.3 Quantitative PCR
    • 7.3.1 Overview
    • 7.3.2 Quantitative PCR: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Digital PCR
    • 7.4.1 Overview
    • 7.4.2 Digital PCR: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe dPCR and qPCR Market - Revenue and Forecast to 2030 - by Product

  • 8.1 Overview
  • 8.2 Europe dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
  • 8.3 Reagents & Consumables
    • 8.3.1 Overview
    • 8.3.2 Reagents & Consumables: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Instruments
    • 8.4.1 Overview
    • 8.4.2 Instruments: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Software & Services
    • 8.5.1 Overview
    • 8.5.2 Software & Services: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe dPCR and qPCR Market - Revenue and Forecast to 2030 - by Application

  • 9.1 Overview
  • 9.2 Europe dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
  • 9.3 Research Application
    • 9.3.1 Overview
    • 9.3.2 Research Application: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Clinical Application
    • 9.4.1 Overview
    • 9.4.2 Clinical Application: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.4.2.1 Europe dPCR and qPCR Market, by Clinical Application, 2020-2030 (US$ Million)
  • 9.5 Forensic Application
    • 9.5.1 Overview
    • 9.5.2 Forensic Application: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe dPCR and qPCR Market - Revenue and Forecast to 2030 - by End-User

  • 10.1 Overview
  • 10.2 Europe dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
  • 10.3 Hospitals and Diagnostic Centers
    • 10.3.1 Overview
    • 10.3.2 Hospitals and Diagnostic Centers: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Pharmaceutical and Biotechnology Companies
    • 10.4.1 Overview
    • 10.4.2 Pharmaceutical and Biotechnology Companies: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Research Laboratories and Academic Institutes
    • 10.5.1 Overview
    • 10.5.2 Research Laboratories and Academic Institutes: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.6 Forensic Laboratories
    • 10.6.1 Overview
    • 10.6.2 Forensic Laboratories: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.7 Clinical Research Organizations
    • 10.7.1 Overview
    • 10.7.2 Clinical Research Organizations: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe dPCR and qPCR Market - Country Analysis

    • 11.1.1 Europe dPCR and qPCR Market, by Country
      • 11.1.1.1 UK
        • 11.1.1.1.1 UK: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.1.2 UK: Europe dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.1.1.3 UK: Europe dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.1.1.4 UK: Europe dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.1.1.4.1 UK: Europe dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.1.1.5 UK: Europe dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.1.1.2 Germany
        • 11.1.1.2.1 Germany: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.2.2 Germany: Europe dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.1.2.3 Germany: Europe dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.1.2.4 Germany: Europe dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.1.2.4.1 Germany: Europe dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.1.2.5 Germany: Europe dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.1.1.3 France
        • 11.1.1.3.1 France: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.3.2 France: Europe dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.1.3.3 France: Europe dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.1.3.4 France: Europe dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.1.3.4.1 France: Europe dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.1.3.5 France: Europe dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.1.1.4 Italy
        • 11.1.1.4.1 Italy: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.4.2 Italy: Europe dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.1.4.3 Italy: Europe dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.1.4.4 Italy: Europe dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.1.4.4.1 Italy: Europe dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.1.4.5 Italy: Europe dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.1.1.5 Spain
        • 11.1.1.5.1 Spain: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.5.2 Spain: Europe dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.1.5.3 Spain: Europe dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.1.5.4 Spain: Europe dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.1.5.4.1 Spain: Europe dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.1.5.5 Spain: Europe dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.1.1.6 Rest of Europe
        • 11.1.1.6.1 Rest of Europe: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.6.2 Rest of Europe: Europe dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.1.6.3 Rest of Europe: Europe dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.1.6.4 Rest of Europe: Europe dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.1.6.4.1 Rest of Europe: Europe dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.1.6.5 Rest of Europe: Europe dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)

12. dPCR and qPCR Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Europe dPCR and qPCR Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Abbott Laboratories
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Thermo Fisher Scientific Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Takara Bio Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Qiagen NV
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Standard BioTools Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Lepu Medical Technology Beijing Co Ltd
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 F. Hoffmann-La Roche Ltd
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Bio-Rad Laboratories Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Agilent Technologies Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms